5-[2-(3,4-dihydroquinolin-1(2H)-yl)-2-oxoethyl]-7-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
Chemical Structure Depiction of
5-[2-(3,4-dihydroquinolin-1(2H)-yl)-2-oxoethyl]-7-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
5-[2-(3,4-dihydroquinolin-1(2H)-yl)-2-oxoethyl]-7-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
Compound characteristics
Compound ID: | G640-0131 |
Compound Name: | 5-[2-(3,4-dihydroquinolin-1(2H)-yl)-2-oxoethyl]-7-(pyrrolidine-1-sulfonyl)-2,3-dihydro-1,5-benzothiazepin-4(5H)-one |
Molecular Weight: | 485.62 |
Molecular Formula: | C24 H27 N3 O4 S2 |
Smiles: | C1CCN(C1)S(c1ccc2c(c1)N(CC(N1CCCc3ccccc13)=O)C(CCS2)=O)(=O)=O |
Stereo: | ACHIRAL |
logP: | 3.3792 |
logD: | 3.3792 |
logSw: | -3.8339 |
Hydrogen bond acceptors count: | 10 |
Polar surface area: | 63.084 |
InChI Key: | OQOJDRLSABZHDW-UHFFFAOYSA-N |